Outcomes of long-pulsed 1064 nm Nd:YAG laser treatment of basal cell carcinoma: A retrospective review.
Lasers Surg Med
; 51(1): 34-39, 2019 01.
Article
en En
| MEDLINE
| ID: mdl-30508262
ABSTRACT
BACKGROUND AND OBJECTIVE:
Recent prospective trials have supported treatment of nonfacial BCC with long-pulsed 1064 nm NdYAG laser based on short-term histologic clearance rates. Studies have yet to identify the long-term clinical clearance rates of this specific laser therapy for BCC. STUDY DESIGN/MATERIAL ANDMETHODS:
This is a retrospective review of BCC treated with long-pulsed 1064 nm NdYAG laser, which have been clinically monitored for at least 6 months, to assess for recurrence and cosmetic outcomes of the treated area.RESULTS:
16 BCC lesions (11 subjects) treated with 1064 nm NdYAG laser were enrolled. Our analysis revealed 100% clearance rate in all subjects (16 of 16 BCC) treated with long-pulsed NdYAG laser based on mean follow-up of 9 months (range 6-15 months). Minimal scarring and no long-term adverse events were noted.CONCLUSIONS:
This study supports the use of 1064 nm NdYAG laser as a therapeutic modality for BCC based on the absence of clinical recurrence upon a mean follow-up of 9 months. As studies progress, we are beginning to observe a potential role for laser as an alternative to patients who refuse surgery, have multiple co-morbidities, or decline non-surgical therapies. Laser treatment with 1064 nm NdYAG is an evolving, promising story that we continue to investigate to optimize parameters. Lasers Surg. Med. 5134-39, 2019. © 2018 Wiley Periodicals, Inc.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Carcinoma Basocelular
/
Terapia por Láser
/
Láseres de Estado Sólido
Tipo de estudio:
Observational_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Lasers Surg Med
Año:
2019
Tipo del documento:
Article